Enguent Jean-Pierre 4
4 · SEALSQ Corp · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
SEALSQ VP Enguent Jean-Pierre Exercises Options, Sells Shares
What Happened
Enguent Jean-Pierre, Vice President, R&DSS at SEALSQ Corp (LAES), exercised options and then sold shares. On 2026-07-06 he exercised/converted 15,000 shares at $0.01 (cost $150). The Form 4 also shows a 15,000-share derivative conversion reported at $0.00. On 2026-07-08 he sold 15,000 common shares in the open market for a weighted-average price of $2.82, generating proceeds of $42,267. The transactions were effected under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction dates: Exercise/conversion reported 2026-07-06; open-market sale reported 2026-07-08.
- Prices and values: Exercise 15,000 @ $0.01 (total $150); Sale 15,000 @ $2.82 (weighted avg) ≈ $42,267. Sale prices ranged $2.73–$2.91.
- Transaction codes: M = exercise/conversion of derivative; S = sale.
- Footnotes: Both the exercise and the sale were made pursuant to a Rule 10b5-1 trading plan adopted October 13, 2025 (F1, F3). F2 notes the sale price is a weighted average and the filer will provide per-trade breakdown on request.
- Shares owned after the transactions: Not specified in the provided Form 4 excerpt.
- Filing timeliness: Reported on 2026-07-08 for a 2026-07-06 transaction — appears timely.
Context
- The sequence (exercise followed by an open-market sale under a 10b5-1 plan) is effectively a planned monetize of option-derived shares; this is commonly a pre-arranged sale rather than an ad hoc decision.
- For retail investors: purchases can signal direct insider accumulation; planned or routine sales under 10b5-1 are less informative about the insider’s current view of the company.
Insider Transaction Report
Form 4
SEALSQ CorpLAES
Enguent Jean-Pierre
Vice President, R&DSS
Transactions
- Exercise/Conversion
Ordinary Shares
2026-07-06$0.01/sh+15,000$150→ 15,000 total - Sale
Ordinary Shares
[F1][F2]2026-07-08$2.82/sh−15,000$42,267→ 0 total - Exercise/Conversion
Employee Stock Option Plan (right to buy)
[F3]2026-07-06−15,000→ 30,000 totalExercise: $0.01From: 2026-06-01Exp: 2032-04-30→ Ordinary Shares (15,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.73to $2.91, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
Signature
/s/ John O'Hara, Attorney-in-Fact|2026-07-08